Medicure Inc. (CVE:MPH – Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$0.87 and traded as low as C$0.68. Medicure shares last traded at C$0.68, with a volume of 4,500 shares traded.
Medicure Stock Down 13.9 %
The business’s 50 day simple moving average is C$0.79 and its 200-day simple moving average is C$0.87. The company has a debt-to-equity ratio of 4.65, a quick ratio of 1.29 and a current ratio of 2.03. The company has a market cap of C$7.10 million, a price-to-earnings ratio of -3.49 and a beta of 0.90.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- Basic Materials Stocks Investing
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Capture the Benefits of Dividend Increases
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What is MarketRank™? How to Use it
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
